Insulet (PODD) shares fell 3.6% in recent Monday trading after Barclays downgraded the medical device company to underweight from equalweight and cut its price target to $274 from $316.
Trading volume stood at over 365,000 shares compared with a daily average of 652,082 shares.
Price: 279.27, Change: -9.78, Percent Change: -3.38